HOGY MEDICAL (3593) FY2026 Q3 Earnings Report

Quick View

Executive Summary

For the cumulative Q3 period, the Company posted a decline in earnings that exceeded the rate of revenue decline, with profit falling substantially. Revenue was ¥28.72B (-4.3% year on year), Operating Income was ¥2.09B (-38.7%), Ordinary Income was ¥1.87B (-42.7%), and Net Income was ¥1.44B (-47.4%). The decline in profit was significantly greater than the decline in revenue, primarily because the Company was unable to absorb fixed costs, including selling, general and administrative expenses.

Factors Affecting Business Performance

【Revenue】Revenue was ¥28.72B, down 4.3% year on year. Although segment information was not disclosed, the Full-Year forecast is ¥39.24B (+0.3% year on year), reflecting a plan premised on a return to revenue growth in Q4.

【Profit and Loss】Operating Income was ¥2.09B (-38.7%), and the Operating Income margin declined from the previous year to 7.3%. Although the cost of sales decreased to ¥19.22B, SG&A expenses increased to ¥7.41B (SG&A ratio: 25.8%), and fixed-cost absorption did not progress. Non-operating income and expenses resulted in a deficit of ¥0.22B (including interest expense of ¥0.08B and foreign exchange losses of ¥0.04B), causing Ordinary Income to decline further to ¥1.87B (-42.7%). Extraordinary income of ¥0.11B (including a gain on the sale of fixed assets of ¥0.10B) temporarily boosted Net Income, but Net Income was ¥1.44B (-47.4%). In conclusion, the Company experienced both a revenue decline and an earnings decline.

Key Financial Indicators

【Profitability】The Operating Income margin was 7.3% and the Net Income margin was 5.0%, with both declining from the previous year. ROE was 1.9%, explained as the product of a 5.0% Net Income margin, total asset turnover of 0.304x, and financial leverage of 1.27x. The low profit margin and asset turnover are the primary factors suppressing ROE. 【Cash Flow Quality】Operating Cash Flow (OCF) was ¥1.80B, or 1.25x Net Income of ¥1.44B, indicating that cash generation capacity was maintained on a simple comparison. However, conversion from EBITDA of ¥6.03B was weak at 0.30x, as increases in trade receivables and inventories tied up funds. 【Investment Efficiency】Capital expenditures were ¥2.91B, below depreciation and amortization expense of ¥3.95B, indicating restrained investment. Free Cash Flow was negative ¥0.27B, meaning that investment and dividends could not be funded solely by OCF. 【Financial Soundness】The Equity Ratio was 78.8%, interest-bearing debt remained limited to ¥10.17B, and the current ratio was high at over 500%, indicating conservative financial leverage.

Cash Flow Analysis

OCF was ¥1.80B, down 76.6% from ¥7.70B in the same period of the previous year. An increase in trade receivables of ¥1.43B and a decrease in trade payables of ¥0.73B were sources of cash outflow, while income taxes and other taxes paid of ¥1.77B were also deducted. As a result, conversion to OCF was only 0.30x against EBITDA of ¥6.03B. Investing Cash Flow was negative ¥2.07B, primarily due to capital expenditures of ¥2.91B. Financing Cash Flow was negative ¥2.95B, including repayments of borrowings and dividend payments. Free Cash Flow was negative ¥0.27B, confirming a structure in which investment and shareholder returns cannot be sufficiently funded through operating activities alone. Cash and deposits on hand were ¥18.28B. Although this is not a level that poses difficulties for funding in the near term, improvement in working capital will determine future financial flexibility.

Quality of Earnings

Current-period earnings included the one-time factor of extraordinary income of ¥0.11B (including a gain on the sale of fixed assets of ¥0.10B); excluding this item, recurring earnings power is at a lower level. Non-operating income consisted primarily of interest income of ¥0.12B and dividend income of ¥0.07B, while non-operating expenses included interest expense of ¥0.08B and foreign exchange losses of ¥0.04B, resulting in a non-operating deficit of ¥0.22B. Although OCF exceeded Net Income of ¥1.44B, this was primarily attributable to non-cash items other than working capital, particularly depreciation and amortization expense of ¥3.95B. Considering the increase in trade receivables and inventories, cash conversion efficiency declined. Comprehensive income was ¥1.60B, and the difference from Net Income of ¥1.44B was limited, as the negative ¥0.86B foreign currency translation adjustment and the positive ¥0.53B valuation difference on securities, among other items, were largely offsetting.

Earnings Forecast and Guidance

Progress against the Full-Year forecast was 73.2% for Revenue, 75.4% for Operating Income, 72.3% for Ordinary Income, and 70.8% for Net Income. The progress rate for Operating Income is close to the standard benchmark of 75%. To achieve the Full-Year forecast of ¥2.77B (-27.3% year on year), Operating Income of approximately ¥0.68B in Q4, equivalent to a 6.5% profit margin, will be required. Meanwhile, Revenue is forecast to increase 0.3% year on year for the Full Year. As this plan assumes a recovery from the cumulative decline of -4.3%, demand trends in Q4 will be key to achieving the plan.

Shareholder Returns

Dividends totaled ¥23.75 for Q1 and ¥23.75 for Q2, for a cumulative ¥47.50. The Full-Year dividend forecast is also ¥47.50, and no additional increase in the year-end dividend is currently expected. The Payout Ratio is 37.2% based on Net Income, which is within a sustainable range. However, because Free Cash Flow was negative ¥0.27B, current-period dividends were not funded by Free Cash Flow and instead rely on cash on hand and deposits of ¥18.28B, among other sources. No share repurchases have been confirmed, and the Total Return Ratio is at the same level as the Payout Ratio.

Risk Factors

1. Operating Leverage Risk: While Revenue declined 4.3%, Operating Income declined 38.7%, indicating high sensitivity to downside earnings risk due to insufficient fixed-cost absorption.

2. Working Capital and Cash Conversion Risk: The ¥1.43B increase in trade receivables and ¥0.73B decrease in trade payables pressured OCF, while the conversion rate of OCF to EBITDA was low at 0.30x. If the accumulation of funds tied up in working capital, including inventories of ¥4.36B, continues, it could lead to a further deterioration in FCF.

3. Capital Allocation Risk: Free Cash Flow was negative ¥0.27B. If capital expenditures of ¥2.91B and dividends of ¥47.50 on a cumulative basis are maintained simultaneously, reliance on cash on hand may continue.

Industry Benchmark (Reference; Company Analysis)

Industry Benchmark (retail)

Profitability and Returns

The Company's profitability exceeds the industry median and is positioned at a high level within the industry.

Growth and Capital Efficiency

The Revenue growth rate is below the industry median, indicating that the Company is lagging in terms of growth within the industry.

Source: Company analysis

Key Points from the Earnings Results

1. The decline in Operating Income (-38.7%) significantly exceeded the Revenue decline (-4.3%), while the increase in the SG&A ratio (25.8%) indicates insufficient fixed-cost absorption. This is a phase in which there remains room for a structural improvement in profit margins.

2. The Full-Year forecast assumes Revenue growth of +0.3% year on year, but cumulative Revenue is -4.3%, making the plan premised on a return to revenue growth in Q4. The consistency between the progress rate (75.4% for Operating Income) and the pace of Revenue recovery will be a key point to monitor.

3. Free Cash Flow was negative ¥0.27B, and dividends (cumulative ¥47.50; Payout Ratio of 37.2%) were not fully covered by Free Cash Flow. The high level of financial soundness, reflected in the Equity Ratio of 78.8%, is providing near-term support.

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings-summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.

---End of Report---